from 3.3 percent in 2016 on the back of rising exports and a robust tourism sector, consistent with a stronger recovery in global demand. Headline inflation rose to 0.7 percent, following higher energy
The opinions of the Independent Financial Advisor on the connected transaction (For the purpose of translation only) 0 The opinions of the Independent Financial Advisor on the connected transaction by Thai Wacoal Public Company Limited Presented to Shareholders of Thai Wacoal Public Company Limited Prepared by 8 March 2019 This English report of the Independent Financial Advisor’s Opinions has been prepared solely for the convenience of foreign shareholders of Thai Wacoal Public Company Limited...
2018 expanded continuously on the back of robust exports and tourism, which is supported by stronger global economic conditions. Exports and tourist arrivals rose by 9.9 percent and 15.4 percent, from
compared to Q4/2017, with respect to the increased demand for crude oil during the winter in Europe, leading to higher utilization rate amongst refineries in the region; driving up price of Dated Brent as
). Total Gross Refinery Margin (Total GRM) rose 67% YoY and 26% QoQ, while Market GRM lowered from the decreasing production volume. Moreover, the average crude price adjusted upward in the quarter, leading
result was increased by Baht 104 million mainly due to an increase in electricity profit, caused by a shorter scheduled maintenance, comparing to the same period of previous year, leading to higher
spread of COVID-19, the government of many countries enacted lockdown measure, leading to the announcement of the temporarily capacity reduction of plant for a long while by customers. As a result, fatty
, in the period of 2017, accumulated amount of 641.0 million baht. Due to an increase of investments in joint ventures. (With“Nomura Real Estate Development” (NRED) – one of world’s leading real estate
their services to all customers. The Company, leading distributor of medical device, is developing new products; medical software, together with plan to shift from distributor to manufacture to serve
their services to all customers. The Company, leading distributor of medical device, is developing new products; medical software, together with plan to shift from distributor to manufacture to serve